WallStSmart

Churchill Capital Corp IX (CCIX)vsChurchill Capital Corp XI Class A Ordinary Shares (CCXI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CCXI leads profitability with a 0.0% profit margin vs 0.0%. CCXI earns a higher WallStSmart Score of 32/100 (F).

CCIX

Avoid

30

out of 100

Grade: F

Growth: 3.7Profit: 3.5Value: 4.7Quality: 4.0
Piotroski: 2/9

CCXI

Avoid

32

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCIX0 strengths · Avg: 0/10

No standout strengths identified

CCXI1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
549.0%10/10

Revenue surging 549.0% year-over-year

Areas to Watch

CCIX4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$394.49M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

CCXI4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-47.0%2/10

ROE of -47.0% — below average capital efficiency

Free Cash FlowQuality
$-26.53M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CCIX

CCIX has a balanced fundamental profile.

Bull Case : CCXI

The strongest argument for CCXI centers on Revenue Growth. Revenue growth of 549.0% demonstrates continued momentum.

Bear Case : CCIX

The primary concerns for CCIX are Revenue Growth, Market Cap, Return on Equity. A P/E of 46.8x leaves little room for execution misses.

Bear Case : CCXI

The primary concerns for CCXI are EPS Growth, Profit Margin, Return on Equity.

Key Dynamics to Monitor

CCIX profiles as a value stock while CCXI is a hypergrowth play — different risk/reward profiles.

CCXI is growing revenue faster at 549.0% — sustainability is the question.

CCIX generates stronger free cash flow (-176,305), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCXI scores higher overall (32/100 vs 30/100) and 549.0% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp IX

FINANCIAL SERVICES · SHELL COMPANIES · USA

Churchill Capital Corp IX (CCIX) is a special purpose acquisition company dedicated to identifying and merging with high-potential technology firms that exhibit strong growth trajectories. With a seasoned management team experienced in public markets and operational scaling, CCIX is strategically positioned to create significant shareholder value through its disciplined approach to acquisition. The company focuses on the dynamic digital transformation landscape, employing rigorous due diligence processes that prioritize not only attractive returns for investors but also the stimulation of innovation within target industries.

Visit Website →

Churchill Capital Corp XI Class A Ordinary Shares

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

Want to dig deeper into these stocks?